Search
Searching Content indexed under Food and Drugs Law by Clayton Utz ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Rights holders rearmed with preliminary discovery powers by Full Federal Court
A prospective applicant for preliminary discovery need only prove that he believes that he MAY have a right to relief.
Australia
23 Dec 2017
2
TGA future business processes on complementary medicines open for discussion
The TGA is proposing a standardised process for pre-market assessments with legislated timeframes and fee structures.
Australia
15 Oct 2017
3
A new frontier for therapeutic goods advertising: consultation paper released
These proposed changes to the Therapeutic Goods Advertising Code are intended to promote four clear objectives.
Australia
29 Sep 2017
4
Proposed amendments to the therapeutic goods regime
The TGA is seeking comments from interested parties on exposure draft bills and proposed changes to the Advertising Code.
Australia
4 Sep 2017
5
Application to list on PBS does not constitute patent infringement per se
Lodging an application for listing on the Pharmaceutical Benefits Scheme does not constitute exploitation of a patent.
Australia
16 Mar 2017
6
Carving out the principles: a comparative review of the Australia and UK Lyrica cases
The differences seem to be from matters of expert evidence more than major variations in application of legal principle.
Australia
24 Nov 2016
7
Commonwealth of Australia v Sanofi: The Full Federal Court decision: patent dispute
The Therapeutic Goods Act does not curtail any person's (or the Government's) right to recover on the usual undertakings.
Australia
14 Jun 2016
8
Injunctions and undertakings in pharma patent fights: the cost of doing business?
The question whether the Commonwealth is actually entitled to any compensation as to damages remains to be determined.
Australia
10 Jun 2016
9
Food products: new Country of Origin requirements announced
Australian consumer affairs ministers agreed to replace existing mandatory Country-of-Origin food labelling requirements.
Australia
17 Apr 2016
10
High Court upholds earlier decision that AstraZeneca's cholesterol-lowering patent is obvious
The High Court has unanimously dismissed AstraZeneca's appeal concerning its low-dose patent for the drug rosuvastatin.
Australia
8 Sep 2015
11
Australia gets compulsory patent licensing laws for pharmaceutical exports to developing countries
Compulsory patent licensing laws are being amended to support export of patented pharmaceuticals to countries in need.
Australia
9 Mar 2015
12
Pfizer case shows protecting your own position isn't anti-competitive
The Court found Pfizer's strategies were legitimate forms of competition in the face of sustained attack by generics.
Australia
 
9 Mar 2015
13
Patent reform: Time for a step change?
Reforms include proposed changes to innovation patents and a review of current arrangements for pharmaceutical patents.
Australia
28 Oct 2012
14
Implementing the TRIPS Agreement in Australia - what's happening?
Developing countries experiencing a health crisis should be able to buy vital medicines from Australia more affordably.
Australia
27 Jun 2012
15
New Arrivals - Some Insights Into The TGA's Risk Management Approach
The changes increase the transparency of the TGA's decision-making processes.
Australia
16 Aug 2010
16
There Was Movement At The Station: The Australian Consumer Law Reforms Are Being Enacted Into Law
Reforms are a turning point in the enforcement of Australian consumer laws. Regulators are being given increased powers and easier enforcement avenues.
Australia
13 Oct 2009
17
Educator Or Promoter - Are You At Risk Of An Identity Crisis?
Pharmaceutical companies should be increasingly wary of implementing aggressive educational campaigns and should familiarise themselves with their compliance obligations.
Australia
15 May 2008
18
Labelling Of Complementary Medicines
The Trade Practices Act includes strict provisions stipulating how and when a product, including a medicinal product, can be said to be "made in Australia".
Australia
23 Sep 2007
19
The Omnitrope Experience ... Is it STOP or GO for Follow-On Biologicals in Australia?
The regulatory processes available for follow-on biologicals differ between jurisdictions; Several issues need urgent clarification for many pharmaceutical manufacturers.
Australia
15 May 2006
20
The NHMRC Amendment Bill 2006 - Greater Autonomy and Transparency
Changes to the NHMRC will not immediately impact on those in the health and medical research sectors, but the question is whether the organisational change will percolate into that part of the Council where the Australian health industry actually has a connection?
Australia
12 May 2006
Links to Result pages
 
1 2  
>>Next